Welcome to our dedicated page for MSLP news (Ticker: MSLP), a resource for investors and traders seeking the latest updates and insights on MSLP stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MSLP's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MSLP's position in the market.
MusclePharm Corporation (OTCMKTS: MSLP) announced participation in the 34th Annual Roth Conference from March 13-15, 2022, in Dana Point, CA. Key executives, including CEO Ryan Drexler and President Sabina Rizvi, will engage in one-on-one and small group meetings on March 14 and 15. The company does not plan a formal presentation during the event. MusclePharm is a leader in sports nutrition, offering various product lines available in over 100 countries, with its Combat Protein series being particularly popular.
MusclePharm Corporation (OTCMKTS: MSLP) has announced a new partnership with Costco US to distribute its MP Combat Energy drink line, set to launch in summer 2022 across Southern California and Hawaii. This marks MusclePharm's first collaboration with a food wholesaler for its energy products. The drinks will be available in a 24-pack featuring three flavors: Grapefruit Lime, Green Apple, and Black Cherry. CEO Ryan Drexler anticipates strong sales based on the success of MusclePharm's protein products at Costco, supported by a partnership with a leading food and beverage broker for further distribution.
MusclePharm Corporation (OTCMKTS: MSLP) has announced a national partnership with Alliance Sales & Marketing to enhance the distribution of its energy drink products, MP Combat Energy and FitMiss Energy. This collaboration aims to leverage Alliance's 20 years of industry experience in expanding MusclePharm's presence in grocery and convenience stores across the U.S. Executives from both companies expressed optimism about the potential growth driven by this partnership.
MusclePharm Corporation (OTCMKTS: MSLP) announced the launch of its reformulated MP Combat Protein Powder in a 6.2-liter tub at Costco US, set for promotion in March 2022. The new formula offers improved taste and mixability, responding to positive feedback from online customers. CEO Ryan Drexler emphasized the company's commitment to meeting consumer demand. This move aims to strengthen MusclePharm's retail presence and appeal to a broader audience.
MusclePharm Corporation (OTCMKTS: MSLP) has announced a significant partnership with Amazon to distribute its new MP Combat Energy drink line, featuring flavors such as Green Apple, Grapefruit Lime, and Black Cherry. The drinks contain 300 mg of caffeine, 600 mg of BCAA Aminos, and zero sugar or calories. The partnership aims to enhance MusclePharm's multi-channel distribution strategy, leveraging Amazon's reach to 200 million Prime members. MusclePharm's CEO expressed confidence in the brand's growth potential, especially in the fast-growing 'good for you' energy drink market.
MusclePharm Corporation (MSLP) reported Q3 2021 results with net revenue of $12 million and a net loss of $(3.9 million). Operating expenses totaled $3.5 million, leading to a gross margin of 0.2% due to rising protein and freight costs. For the nine months ended September 30, 2021, the company achieved net revenues of $40 million and a net loss of $(6.1 million). Looking ahead, MusclePharm expects annual sales of $30 million in 2023 from its new energy drink line and is optimistic about sequential revenue growth in Q4 2021.
MusclePharm Corporation (OTCMKTS: MSLP) will release its third quarter financial results on November 15, 2021, after market close. A conference call is scheduled for the same day at 1:30 PM PT to discuss the results. Interested investors can access the call by dialing (800) 667-5216 for U.S. callers or (303) 223-2688 for international participants. The call will be accompanied by a live webcast available on the company’s website, which will be archived for 30 days.
MusclePharm Corporation (OTCMKTS: MSLP) has announced a partnership with Jason May, a former Rockstar Energy executive, to enhance its beverage team. May will oversee the marketing strategy for two new energy drinks, MP Combat Energy and FitMiss Energy. MP Combat Energy is set to launch in fall 2021 with three flavors, backed by over $1 million in pre-production sales. The initiative aims to solidify MusclePharm's position in the growing energy drink market, leveraging expertise and existing distribution channels.
MusclePharm Corporation (OTCMKTS: MSLP) announced definitive agreements with institutional investors for gross proceeds of approximately $7,050,000. This includes a private placement of 14% Original Issue Discount Senior Secured Notes totaling around $8.2 million, due on April 13, 2022. The company plans to issue warrants for the purchase of 17,355,700 shares at an exercise price of $0.78. The net proceeds will support general working capital and the rollout of its new functional energy drink line, MP Performance Energy.
MusclePharm Corporation (OTCMKTS: MSLP) announced the successful closure of $1.0 million in pre-orders for its upcoming MP Performance Energy drink, which is set to ship starting September 2021. Initial market availability is planned for this September, and FitMiss products will hit the shelves by the end of 2021. CEO Ryan Drexler expressed confidence in the beverage line, projecting $30 million in annual sales by 2023. In recognition of the pre-order milestone, MusclePharm will donate 2,500 cases to first responders.
FAQ
What is the market cap of MSLP (MSLP)?
